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Summary of thesis  
Background: Lyme borreliosis (LB) caused by the bacteria Borrelia burgdorferi 
sensu lato (Bbsl) is the most common tick transmitted infection in Europe. LB is 
a multi systemic infection that develops when the bacteria disseminate from the 
local tick bite to different organs and tissues. Neuroborreliosis (NB) is the 
neurological manifestation of LB and may affect both the peripheral and the 
central nervous system. A variety of neurological symptoms are observed; 
aseptic meningitis (AM) and facial nerve palsy (FNP) are the major 
manifestations in children. The incidence of FNP and AM in children, as well as 
the rate of FNP and AM caused by LB is not well described and may vary 
between areas. Furthermore, it is not well documented how often FNP caused by 
LB is associated with AM.  
Finally, the clinical presentation of NB and the result of diagnostic tests may 
differ between areas and even between children and adults. All these issues have 
been scarcely addressed in a population based setting in children.  
Aim: The aim of this thesis was to study the epidemiology of childhood NB, 
FNP and infectious meningitis in an endemic area of LB in south western 
Norway. Further, to evaluate demographical, clinical and laboratory aspects of 
NB, FNP and infectious meningitis in children, and to study the interplay 
between these conditions.   
Methods: In a population based study performed during 1996-2009, children up 
to 14 years old referred to Stavanger University Hospital with suspected NB, 
including acute FNP, were investigated by a standard procedure including a 
lumbar puncture. Except when bacterial meningitis (BM) was confirmed, Bbsl 
serological tests were performed in serum and CSF in all children with CSF 
pleocytosis. In paper I-III, NB was diagnosed in children with neurological 
symptoms compatible with NB and with positive Bbsl antibodies or recently 
EM. In paper IV, Lyme meningitis (LM) was diagnosed in children with CSF 
pleocytosis and symptoms suggestive of NB in combination with Bbsl antibody 
index (AI) (confirmed LM) or Bbsl antibodies in serum or CSF (probable LM).   
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Results: The annual incidence of NB in children up to 14 years of age was 
21/100.000. A seasonal distribution was observed, all children with NB were 
diagnosed from April to December. The highest incidence of NB was found in 
the age group 6-7 years. Near all (98%) of children with NB had CSF 
pleocytosis, and FNP was observed in 69% of children with NB. The level of 
CSF inflammation, the proportion of children with positive Bbsl antibodies in 
serum and CSF, and Bbsl AI, all increased with the duration of symptoms before 
lumbar puncture. In addition, the level of CSF inflammation differed between 
clinical groups. 
The incidence of FNP was 21/100.000, and NB was diagnosed in 65% of 
children with FNP. Tree quarters of children with FNP had CSF pleocytosis. No 
other cause than NB was diagnosed in children with both FNP and CSF 
pleocytosis. Children with FNP without NB were diagnosed through the whole 
year and were evenly distributed in all age groups, and differed from the age 
distribution of children with FNP and NB.  
The incidence of infectious meningitis in children was 38/100.000 and 67% of 
these were caused by LM. Age, month of admission and clinical and laboratorial 
characteristics differed between children with LM, NLAM and BM. The positive 
predictive value for having LM if the child had FNP or meningism as the only 
symptom was 97% for both variables. The negative predictive value for not 
having LM if the child did not have a history of EM, or cranial nerve 
involvement or meningism as the only symptom was 95%. 
Conclusion: In this population based study, the incidence of NB, incidence of 
FNP and proportion of FNP caused of NB were among the highest reported in 
children worldwide. Furthermore, nearly all children with NB had CSF 
pleocytosis. Our results suggest that in children with possible NB, the duration of 
symptoms and clinical characteristics must be included in the interpretation of 
laboratory results. Finally we found LM to be the major cause of infectious 
meningitis. In children with CSF pleocytosis, distinct clinical characteristics 
distinguished the majority of children with LM from NLAM.   
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1. Introduction 
Zoonotic infections are human diseases acquired from animals. Frequently, the 
infection is transmitted from animal hosts to humans via an arthropod vector. 
Lyme borreliosis (LB) is a tick-borne infectious disease and is the most common 
zoonosis of the northern hemisphere. The European vector tick, Ixodes ricinus, is 
able to feed off different animal species including humans. During the tick bite 
the subcutaneous tissue and the bloodstream may be contaminated so the tick 
and the host exchange microbes. Many different tick-borne infections are known 
in human medicine, however in the veterinary medicine it is an even more 
challenging area. Furthermore, by cooperation between human and veterinary 
medicine, the contribution of environmental sciences has developed the research 
into a complex and fascinating ecological medicine.  
Since the discovery 30 years ago of the Bbsl spirochete as the cause of LB, the 
infection has been intensively studied. However, the complexity of Bbsl 
distribution and the variety of manifestations caused by different genospecies of 
the Bbsl complex make community based studies important. The LB clinical 
picture seems to be different even between children and adults, making specific 
studies of children essential to improve management of LB.   
 
1.1 Lyme borreliosis 
1.1.1 History  
In October 1975, two mothers, Polly Murray and Judith Mensch from the 
community of Lyme, Connecticut, USA, contacted the Connecticut State Health 
Department to report their worry concerning a high number of children in the 
neighbourhood who simultaneously were diagnosed with what was suspected to 
be juvenile arthritis (1). The investigation initiated by these observant women 
ended in the etiological discovery of LB. In 1977, Steere and colleagues 
published the paper “Lyme arthritis: an epidemic of oligoarticular arthritis in 
children and adults in three Connecticut communities” (2). They described 
characteristic skin lesion preceding the arthritis, observed a peak incidence of 
new cases during summer and early fall, and reported a positive effect of 
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treatment with antibiotics. They suggested that an unknown infectious agent was 
transmitted by an arthropod vector. In 1982, Willy Burgdorfer reported the 
observation of a spirochete in the gut of Ixodes ticks that was probably the cause 
of LB (3). Further, in 1983 the spirochete was isolated from blood in patients 
with LB (4).  
Interestingly, more than hundred years earlier, the first bacteria ever observed in 
human blood were reported of the young German physician Otto Obermeyer in 
1873 (5). The bacteria he discovered was the spirochete B recurrentis, a 
representative of the second branch of B spirochetes and the nearest and only 
genetically relative to Bbsl.  B recurrentis is transmitted by human body louse, 
and are still a significant problem in poor environments when causing relapsing 
fever (1).  
Furthermore, European cases of LB have probably been described in several 
reports through the whole of the 19th century (6-11). All these reports described 
dermatological or neurological manifestations, later confirmed to be the main 
manifestations of LB in Europe (12). This was in contrast to the observation of 
LB in US where the majority of disseminated cases were Lyme arthritis (13).  
Three major human pathogenic Bbsl genospecies were identified worldwide. 
These Bbsl genospecies: B afzelii, B garinii and Bb sensu stricto were all found 
in European Ixodes tics. In contrast, only Bb sensu stricto were identified in US, 
and this difference was thought to explain the unique difference in clinical 
characteristics of LB between Europe and US (13-16).   
The final important step in the history of LB was taken when Steere and colleges 
confirmed that antibiotic treatment was an effective therapy for LB (17). 
However, for many years, single Scandinavian patients with erythema migrans 
and meningoradiculitis (Bannwarth syndrome) following tick bites had already 
been successfully treated with antibiotics (6, 9).   
 Interestingly, in 1962, Brennaas and Ræder reported the observation of 13 
patients with meningoencephalomyeloradiculitt occurring from May to 
November in the area of Sunnhordland, the Norwegian coastal region north of 
the area studied in this thesis (10). Ten of the patients had reported tick bite of I. 
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ricinus prior to the illness, and six of these patients developed an erythema 
during the course of infection. The authors concluded that this was undoubtedly 
erythema migrans (EM), today known as the patognomonic manifestation of 
early LB. This was twenty years before the etiological cause of LB was 
discovered, and the authors proposed that this probably was an I. ricinus 
transmitted endemic viral infection. Retrospectively, it is most probably that they 
described patients with neuroborreliosis (NB), the neurological manifestation of 
LB (18). Brennaas and Ræder also reported that half of the patients admitted to 
their local hospital with aseptic meningitis (AM) from 01 July 1959 to 31 
December 1961 seemed to have a tick transmitted endemic infection. None of 
the patients were treated with antibiotics, and the authors thereby provided 
important clinical information about the natural course of untreated NB. All 
patients complained of dorsalgia, except a 5 years old girl who was the only 
child in the study. The adult patients had intense radicular pain lasting for up to 5 
months. Nearly all patients had peripheral or cranial nerve paresis. Seven out of 
13 patients had sign of cerebral affection, and about half of the patients had 
persistent pareses two months after the start of symptoms. Even seven month 
after the start of symptoms, two out of 13 patients had remaining low-grade 
pareses in the upper-extremities. The authors concluded that compared to the 
patients with other causes of AM, the patients with tick transmitted 
meningoencephalomyeloradiculitis had a painful and prolonged illness. As 
reported elsewhere in the literature, some patients probably even got permanent 
sequalae (19). 
Today, patients diagnosed with NB are effectively treated with specific 
antibiotics. However, the diagnostic process is still challenging. Furthermore, 
even the small study from Sunnhordland points to differences in clinical 
characteristics between adults and children with NB, which was later confirmed 
by others (20, 21). During the next decades, the majority of studies of NB have 
been performed in adults, and the results from such studies may not be 
representative for children with NB. Therefore, more clinical studies in children 
with NB were clearly needed.   
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1.1.2 The vector tick 
Ticks are obligate hematophagous arthropods that parasitize every class of 
vertebrates in almost every region of the world. There are 2 major tick families. 
The Ixodidae, or “hard ticks,” so called because of their sclerotized dorsal plate, 
are the most common and most medical important. Hard ticks feed only once in 
every stage of their life cycle, in contrast to the fast feeders, the Argasidae, or 
“soft ticks” (22). Ticks may have appeared 225 millions years ago, when they 
parasitized on reptiles (23). 
Currently, only mosquitoes are more important than ticks as vectors of human 
infectious diseases in the world, but in North America and Europe ticks are most 
important (22).  
I. ricinus is the most important of the Ixodes species transmitting Bbsl in Europe. 
I. ricinus is the vector for several different human pathogenic micro-organisms, 
and LB is by far the most frequent tick transmitted infection in Europe (24). Tick 
borne encephalitis caused by a flavivirus is the second most common tick 
transmitted disease in Europe. There are a few cases of TBE reported every year 
at the Southeast coast of Norway, however so far not observed in persons living 
in the study area of this thesis (25). Finally, co-infection in LB patients with 
Anaplasma phagocytophilium should be considered in cases with recurrent fever 
and bone marrow depression (26). Anaplasmosis in animals is a prevalent 
disease in the study area; however, no children have been diagnosed with human 
anaplasmosis in the study period. This may be caused of to low awareness of the 
disease (27). 
I. ricinus ticks are found in coastal areas south of the polar circle. Norway forms 
a part of the northern distribution border of I. ricinus in Europe. There are local 
areas and regions with high endemic tick populations (28). LB is also 
geographically localized, and occurs only in foci with optimal conditions for the 
ticks and animals involved in the circulation of Bbsl. However, a number of 
events can disturb these associations, including macroclimatic changes, 
urbanization, and deforestation (22). 
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I. ricinus develop through four stages, i.e.; egg, larva, nymph and adult tick 
(figure 1). A new developmental stage is initiated when the tick takes a meal of 
blood on host animals (figure 3).  
Most of the time during nonparasitizing phases, the tick is on or near the surface 
of the soil. The tick is sensitive to variation in temperature and humidity. 
Thermohygrometric stress influences both the survival of the tick during 
diapause in winter and during questing activity (29). The tick becomes active 
when the temperature exceeds 4-6 o C (30). Desiccation is an important threat to 
the tick, and this limits the tick in host-seeking activity in climbing vegetation. 
Exposed to the sun, the tick must descend to the moist conditions at the base of 
the plant to restore its fluid content by uptake of atmospheric water (24, 31). In a 
Swedish study, the mean questing height for nymphal ticks was 30-39 cm in low 
vegetation and 50-59 cm in high vegetation. All stages of ticks were found 
between 10-140 cm over the ground (32). 
In addition to climate conditions, the day length is known to affect the activity of 
I. ricinus, however Ixodes tics are frequently hunting for a host during night (24, 
33). During the last decades, the number of I. ricinus ticks seems to have 
increased in northern Europe, partly due to climatic changes, increased roe deer 
population and changes in habitat structure (34).  
Larvae and nymphs feed on mammals, reptiles and birds. Adult ticks feed on 
large mammals (figure 3). Human beings can be incidental hosts for all three 
stages of the I. ricinus lifecycle. However, questing larval ticks are not usually 
infected and adult ticks rarely feed on humans, and consequently the nymph tick 
is the most likely cause of transmission of Bbsl to humans (24). The infectivity 
of the animal called a reservoir host, the tick infestation rate and the host density 
are major variables determining the epidemiology of tick-transmitted diseases 
(22).  
Nymphs suck blood for 4-5 days and increase in size to about 10 -20 times their 
unfed body weight (35). The transmitting process of Bbsl from the tick gut to the 
human skin usually takes more than 24 hours; however, cases have been reported 
where it has taking less time (36-38). Bbsl is connected by specific outer surface 
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proteins (Osp) to specific proteins in the tick gut during the non-parasiting phase. 
However, these protein genes are turned off when blood enters the tick bowel. 
The spirochete moves to the salvia gland of the tick and there it is joined to 
specific tick saliva proteins, and finally the Bbsl seems to be secreted into the 
victim. The transmission from infected nymphal ticks of one cohort to larval 
ticks of another via reservoir hosts is largely responsible for LB spirochete 
maintenance in nature (35). Furthermore, there are indications that nymphal ticks 
infected with Bbsl have survival advantages compared to un-infected Ixodes tics 
(29).   
 
1.1.3 The host 
I. ricinus is able to parasite a wide range of vertebras with the purpose of sucking 
the critical meal of blood. Regarding Bbsl, hosts are divided into groups of Bbsl 
reservoir-competent or not competent (figure 3). It is believed that this difference 
of host properties is due to difference in the host immune systems. A reservoir 
competent host will let the invading Bbsl spirochete multiply and be transmitted 
in good condition to the next parasiting ticks (35). Different Bbsl genospecies 
seem to have different reservoir-competent animals. Rodents and squirrels are 
the main reservoir for B afzelii, and birds are important reservoirs for B garinii 
in Europe, as shown in figure 3 (26). Roe deer and moose on the other hand, are 
believed not to be a reservoir-competent host, however deer have a unique host 
role for adult female ticks. They feed off deer before getting fertilized and 
thereafter producing 2000-3000 eggs (39). 
In humans, a study from US showed that children are more frequently bitten by 
Ixodes ticks than adults (40). In a Scandinavian epidemiological study the 
location of tick bites were reported. Children had about half of their bites in the 
head and neck region, in contrast to only two percent in adults (12). This 
difference may be the reason for the difference between children and adults 
regarding the clinical manifestations of LB.  
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       Foto: Vivian Kjelland 
Figure 1. I. ricinus ticks named in order by increasing size: larvae, nymph, adult male 
and adult femal. Printed with permission.  
     
 
1.1.4 The Borrelia burgdorferi sensu lato  
Borrelia species are gram-negative microaerophilic mobile spirochetes. Among 
borreliae, Bbsl is the longest and narrowest (20–30 x 0.2– 0.3 Pm) and has the 
least flagella (figure 2). Uniquely, the flagella are periplasmatic localised inside 
the outer membrane of Bbsl, in contrast to extra cellular flagella in most other 
bacteria. As a skeleton the flagella in Bbsl makes the shape and directs the 
swimming movement. The asymmetric rotation of the periplasmatic flagella-
bundles generates backward moving waves along the cell body that propels the 
Bbsl forward. The unique movement enables them to swim efficiently through 
highly viscous media, such as connective tissue, where the movement of other 
bacteria is reduced or inhibited (35, 41). The top speed of Bb measured in vitro 
seems to be faster then the speed of the phagocyting human cells (42), indicating 
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possible clearance difficulties in humans. Bbsl may migrate extracellular and 
chemotactic mechanisms may guide the spirochete (43).  
Presently, 17 different Bbsl strains are known worldwide (37). Eleven 
genospecies of Bbsl have been observed in Europe, among them the three main 
pathogenic species; B afzelii, B garinii and Bb sensu stricto. In addition, B 
spilimanii and B bavariensis are found capable of developing the multisystemic 
infection of LB. B bissettii, B lusitaniae and B valaisiana are rarely detected in 
patients, but are not recognized as important pathogens (26, 44). However, B 
valaisiana was recently identified for the first time in Norway (45).   
 
 . 
 
      Foto: Sverre-Henning Brorson,  
Figure 2. Borrelia burgdorferi sensu lato (transmission electron microscopy) . 
Printed with permission.         
 
Furthermore, multiple molecular mechanisms helping the spirochete to survive 
the immunological system of the host have been observed.  Different Osp are 
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expressed on Bbsl living in ticks and in mammals. Even spatiotemporal variation 
of Bbsl Osp`s within the host or tick has been observed. The genome of Bbsl 
consists of a small linear chromosome and most unusual, 9 linear and 12 circular 
plasmids. The plasmid genome encodes different surfaces exposed lipoproteins, 
allowing for extensive antigen variation and helping the spirochete to survive. 
Nevertheless, once Bbsl is discovered in the body, the innate immune system 
initiates the neutralizing of the spirochete (46). However, the spirochete has 
mechanisms to neutralise the immune system of the host as well. A diversity of 
tick salivary proteins is believed to interact with and reduces the efficiency of the 
host immune system. The knowledge in this area is growing because it is a focus 
of research in order to develop a vaccine against LB (35). No toxins produced by 
Bbsl have been found, however the spirochetes invasiveness is uncommonly 
effective. The manifestations of tissue pathology in LB are therefore believed 
mainly to be due to host inflammatory reaction (1). 
 Different human pathogenic Bbsl species seem to have certain organ specific 
preferences and consequently different clinical manifestations and outcomes. B. 
afzelii is dermatotropic, B. garinii appears to be the most neurotropic agent, and 
Bb sensu stricto, is the most arthrotropic genospecie (47). However, all three 
genospecies are capable of invading the nerve system causing NB (48, 49). 
Usually, infectious agents enter the CNS by the haematological route. In 
addition, Bbsl is probably able of entering CNS by following peripheral nerves 
from the site of the tick bite (50).  
Recently, the prevalence and genotypes of Bbsl infection in Ixodes ricinus ticks 
were studied in southern Norway, in a neighbouring county of the study area in 
the thesis (45). The overall percentage of nymphal ticks being infected with Bbsl 
was determined to be 24.5%, which is a high number compared to previous 
Scandinavian studies (51). The most prevalent Bbsl genospecie identified was B. 
afzelii (61.6%), followed by B. garinii (23.4%) and Bb sensu stricto (10.6%).       
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Figure 3: Life cycle of I. ricinus and infectious cycle of the European Bbsl 
genospecies. The size of the animal indicates the relative importance of the host. 
The size of the circles indicates the relative involvement of the different 
vertebrate reservoirs for the different genospecies. Cross indicates a non-
reservoir host (37). Reprinted with permission from EUCALB representative, 
J.Gray. 
 
        
 
 
 
1.1.5 The clinical picture of LB 
LB is a multisystemic infection (13). The development of LB can only occur 
after a bite by Bbsl infected Ixodes ticks. However, in the majority of humans 
invaded by the spirochete, the immunological reaction and the production of 
Bbsl antibodies are probably sufficient to halt the development of LB. This is an 
interpretation from studies in endemic areas of LB, where the seroprevalence of 
Bbsl antibodies is much higher then the incidence of patients diagnosed with LB 
(52-54).   
 If a human is infected, the course of LB may develop through three following 
stages (13, 15, 26, 55-57). The first stage of LB usually develops as a local skin 
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infection. Days to weeks after the tick bite, a slowly expanding skin lesion, 
erythema migrans (EM), may develop from the site of the tick bite (figure 4). 
EM may be misdiagnosed. However the erythema of cellulites, insect bites, 
ringworm, granuloma annulare or nummular eczema do not have the steady 
enlargement of an inflammatory ring commonly leaving the central zone pale, as 
developed when Bbsl disseminate from the bite location (58). Flu-like symptoms 
sometimes accompany the local infection. Borrelia Lymphocytoma (LC) is a 
subacute skin manifestation developing in areas with loose skin, like the earlobe 
and nipple. LC is an uncommon manifestation of LB compared to EM, which is 
the overall most frequent manifestation of LB. However, in Europe, children 
develop LC more often than adults, corresponding with the higher frequency of 
tick bites in the ear region in children than in adults (12, 59). In Europe, B. 
afzelii is the major genospecie causing skin infection (60, 61). Correspondingly, 
B afzelii is also the most frequent Bbsl genotype found in I. ricinus in 
Scandinavia (45). 
 
        Foto: Jostein Førsvoll 
Figure 4. Erythema migrans., Printed with patients permission. 
 
 21 
In the second stage of LB, developing within weeks to months after a tick bite, 
the spirochete has disseminated to different areas of the skin or to other organs. 
In a German epidemiological study in children, the interval from a tick bite to 
the onset of symptoms of NB was ranging from two to 12 weeks, with a median 
time of five weeks (62). In addition to the skin and nerve system, Bbsb has been 
observed in myocardium, spleen, liver, muscle, bone and retina. Consequently, a 
variety of signs and symptoms may accompany the early stage of disseminated 
LB (57, 61).  
Despite an active immune response, the spirochete may survive in localised 
niches in the human body for months and years (50). The third stage, late LB, is 
uncommon but develops in untreated cases more than six months after a tick 
bite. Late NB or Lyme arthritis may develop in European children, but the late 
manifestation in skin, acrodermatitis atrophicans (ACA), is observed 
predominantly in adults (26, 63). Late NB with encephalopathy is rare, 
especially in children. It should not be diagnosed in the absence of laboratory 
evidence of Bbsl infection. The symptoms include memory loss, depression, 
sensory polyneuropathy or spastic paraparesis, probably caused by direct 
infection of the nervous system.  
Some manifestations of Lyme encephalopathy may resemble those of chronic 
fatigue syndrome or fibromyalgia. This condition may also be triggered by a 
preceding Bbsl infection (37). A multi-authored international review of 'chronic' 
LB concluded that despite strong advocacy by some physicians and patient 
groups, the "assumption that chronic, subjective symptoms are caused by 
persistent infection with Bbsl are not supported by carefully conducted 
laboratory studies or by controlled treatment trials. Chronic Lyme disease, which 
is equated with chronic Bbsl infection, is a misnomer, and the use of prolonged, 
dangerous, and expensive antibiotic treatments for it is not warranted" (64). 
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1.1.6 Treatment and prognosis  
All stages and organ manifestations of LB are efficiently treated with antibiotics 
(61, 63). However, tissue damage secondary to the inflammatory process may 
lead to long lasting sequelae.   
In-vitro studies have shown that Bbsl is susceptible to tetracyclines, most 
penicillins, many of the second- and third-generation cephalosporins, and 
macrolides. Parenteral administration has been preferred in patients with 
meningitis and radiculitis. Oral treatment has been reserved for patients with 
uncomplicated facial palsy (26). A recent multicentre, double-blind, randomised 
trial done in Norway have provided convincing evidence that oral doxycycline is 
as effective as parenteral ceftriaxone for any of the primary manifestations of 
early NB in adults (65). However, doxycycline is contraindicated in children 
younger than 8 years of age. In a retrospective study of Swedish children with 
NB, the outcome of treatment with intravenous beta-lactam antibiotics or oral 
doxycycline for 10 days was reported and no differences regarding outcome 
were found between the groups (66).   
Most patients with LB have an excellent prognosis. Although most 
manifestations of LB seem to resolve spontaneously without treatment, antibiotic 
treatment may speed the resolution of symptoms and signs, and will prevent the 
progression to the later stages of the disease (26). 
No vaccine against Bbsl for humans is presently available (26). Furthermore, 
antibiotic prophylaxis after a tick bite is not recommended, supported by a recent 
Swedish study. In 3 month follow up, only four out of 397 persons who removed 
a biting tick developed Bbsl seroconvertion, and only one person developed 
clinical LB (67). If living in tick habitat, regular inspection of the skin and 
prompt removal of any tick is effective in the prevention of Bbsl transmission 
(37).   
 
1.1.7 Epidemiology of LB  
Epidemiology is “the study of the distribution and determinants of disease 
frequency in human populations.” In addition, it is “the branch of medical 
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science dealing with the control of epidemics,” which has an important role in 
disease prevention at a population level (68). The Greek physician Hippocrates 
has been called the father of epidemiology. He is the first person known to have 
examined the relationships between the occurrence of disease and environmental 
influences. He connected the terms epidemic, for diseases that are seen at some 
times but not others, and endemic, for diseases usually found in some places but 
not in others (69).    
Experimental studies provide stronger clinical evidence than observational 
studies do, however observational studies may provide unique information about 
exposure in conditions and populations where ethical considerations limit the 
possibility for experimental design of studies (68). There are different types of 
observational studies, including cohort studies. In population-based cohort 
studies, the cohort is the entire or a section of the general population with 
specific characteristics, such as age. Specific exposure or characteristics in the 
population without the disease of interest at baseline are followed up over time 
(70). Interpretation of specific observations depends on the properties of 
performed tests (sensitivity and specificity) and the prevalence of the condition 
in the studied population, defining the positive predictive value (PPV) of an 
observation (71). Based on observations in population studies, the properties of a 
disease can be calculated. In the first paper describing Lyme disease, the 
condition was described as a probable epidemic disease (2). However, nowadays 
LB is usually termed as an endemic infection found closely related to the 
distribution of Ixodes ticks, although the seasonal activity of the tick cause 
epidemic clusters of patients with LB during the summer and autumn.  
The main exposure in the epidemiological studies of LB is the bite of a Bbsl 
infected Ixodes tick. The frequency of such bites varies with the size of the local 
tick population, the tick activity and the proportion of ticks infected with 
different pathogenic Bbsl genospecies (31, 35, 36). Furthermore, the activity and 
behaviour of the human population in the tick endemic areas, the primary and 
secondary prevention habits, e.g. avoiding tick bites will influence on the 
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number of persons getting a tick bite. Finally, early removing of ticks has an 
impact on the incidence of infected persons.  
The different determinants of LB are variable studied. In vitro studies on ticks, 
the Bbsl spirochete and animal models of LB have revealed the complex 
interaction between causal factors (1, 50). The epidemiology studies of LB are 
closely interconnected to clinical studies, because the diagnosis of LB depends 
on the appearance of suspicious clinical signs and laboratorial results including 
serological tests. These findings are then the basis of the diagnostic definitions 
(63). Thereby, clinical studies are dependent on epidemiological knowledge. 
There are few epidemiological studies from Europe involving all stages and 
manifestations of LB. In Norway, like in many European countries, only 
disseminated and late LB cases are notifiable (72). However, in a comprehensive 
Scandinavian study from an area of the southern part of Sweden comparable to 
the study area of this thesis, an overall annual incidence of LB of 69 pr 100.000 
inhabitants was reported (12). They demonstrated that parts of the southern 
Scandinavia are among the areas with the highest incidence of LB in Europe. 
However, the incidence varied between geographical regions which have been 
demonstrated to be influenced by local variation of climate (73-75). In addition, 
Berglund and co-authors demonstrated that the incidence varied with age; the 
youngest and oldest persons had the highest incidence of LB (12). In the study, 
77% of 1471 patients with LB had local infection presenting as EM. However, 
the most frequent manifestation of disseminated LB was NB, observed in 16% of 
all LB cases. Furthermore, the incidence of NB was higher in children than in 
adults. 
The incidence of LB in Rogaland County is reported to be close to the median 
compared to other Norwegian counties (72). However, due to the dense 
population in Rogaland, this county contributed to the second most NB cases in 
Norway the last ten years (76). Strikingly, in a study from all parts of Norway, 
20 % of healthy sheep in Rogaland were found to have positive Bbsl antibodies, 
the highest reported incidence in the study (77). 
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In addition to geographical distribution, the occurrence of LB seems to have 
specific age related and seasonal distribution. A follow up study of a defined 
population and with a study period for several years may provide important 
information about these specific properties of LB.      
 
 
 
1.2  Neuroborreliosis 
1.2.1 Clinical picture 
NB is known as a great imitator of multiple neurological diseases (78). As a 
consequence of the imprecise diagnostic tests of NB and the high frequency of 
tick bites in the general population in endemic areas, the diagnostic process 
concerning NB is challenging. In patients with NB, EM has been recognised 
only in a minority of cases, both in children and in adults (12, 62, 79). 
Meningoradiculitis, either with paresis or as a radicular pain syndrome named 
Bannwarth syndrome, is the major manifestation of NB in European adults (8, 
11, 20). A Danish epidemiological study reported that the clinical picture of NB 
in children differed significantly compared to adults, and that the incidence of 
NB was significantly higher in children than in adults (21). Children infrequently 
had radical pain syndromes. The occurrence of a monosymptomatic paresis 
(usually facial paresis) without concomitant pain, fever or neck stiffness was 
only reported in children. In a comprehensive prospective multicentre study in 
German children, it was confirmed that acute peripheral facial nerve palsy (FNP) 
and aseptic meningitis (AM) were the predominating manifestations of NB in 
European children (62). Furthermore, in children with NB they observed 
individual cases with other cranial neuropathies and children with several 
different cranial neuropathies occurring simultaneously. CNS affection was 
infrequent, but cases of focal encephalitis, Guillain-Barre syndrome, acute 
transverse myelitis, pseudotumor cerebri and acute ataxia were described. 
Most studies evaluating the epidemiology and clinical picture of NB in children 
are from earlier periods when newer and more sensitive and specific antibody 
tests were not available, and few population based studies of European NB have been 
performed in children. Furthermore, no studies have evaluated the clinical 
characteristics of childhood NB in the endemic areas of Norway. 
 
1.2.2 Facial nerve palsy 
Facial expression is important for a child’s communication. FNP is therefore a clear 
sign of illness and difficult to ignore (figure 5).  
 
 
 
 
 
 
 
 
 
Figure 5; Facial nerve palsy on the right side.   Foto: Jostein Førsvoll 
 
Since Dr Charles Bell, nearly 200 years ago, described the facial nerve and how the 
facial palsy developed when the nerve was injured, the aetiology of “Bell`s palsy” has 
been studied (80). Historically, the most common identified cause of FNP in children 
has been otitis media (81). For other cases, an infectious aetiology was suspected, and 
the connection between FNP and meningitis was observed in Scandinavia studies prior 
to the recognition of LB (82, 83). Furthermore, multiple cranial neuropathies were 
described simultaneously (84).  
A microbiological cause of FNP was discovered with the description of NB. In the 
first study from US reporting neurological manifestations in Lyme disease, cranial 
neuropathy was found to be common, and the facial nerve was the most frequent 
peripheral nerve involved (85). This was later confirmed in European studies (86-89).  
LB has been identified as the causative agent in different proportions of children with 
FNP, ranging from only a few percent to 60% (62, 88, 90). Furthermore, the 
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frequency of FNP associated with meningitis varies considerably between 
studies (13, 56).  
In a study from the Northern Norway, a non endemic region of Bbsl and with a 
low occurrence of LB, the low incidence of FNP in children as compared to 
adults, has been confirmed by other authors (91, 92). A more recent study from 
the most Southern part of Norway which is endemic for LB, a slightly higher 
incidence of FNP in adults was found compared to the study from Northern 
Norway (93). In this area, 10% of adults with FNP were found to have NB. 
Similar studies in children in areas endemic for LB are lacking.  
Studies in non-human primates have discovered that the inflammation of Bbsl 
are primarily localised to nerve roots, dorsal root ganglia, and the leptomeninges 
(16). As mentioned above, it has been proposed that Bbsl in addition to the 
haematogenous pathway may invade the CNS by migrating along peripheral 
nerves (50). This is partly based on the observations that FNP in NB more often 
occur at the same side as the tick bite (62).   
Some authors have argued that a CSF evaluation should be performed in all 
children with FNP in LB endemic areas, to establish or exclude the diagnosis of 
NB, however, this has been debated (94, 95). In addition, the treatment 
recommended for FNP caused by LB has been different depending of whether 
CSF pleocytosis was detected or not (15, 88, 95-97). Outcome studies of FNP in 
childhood LB shows mild to moderate impairment of the facial nerve in up of 20 
% of children 2 years after treatment with antibiotic (98). However, treatment 
does not seem to have impact on the prognosis of FNP, and the main reason to 
treat with antibiotics is to prevent further development of NB manifestations (88, 
95). No study has been performed in children with FNP in an endemic area of 
LB in Norway. Furthermore, even though there is evidence of a high incidence 
of meningitis in children with FNP in general, few population based studies have 
systematically evaluated children with FNP by a lumbar puncture (LP).  
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1.2.3 Meningitis 
  Microbes crossing the blood – brain barrier activate the innate immune system 
in CNS. The production of chemokines regulates and directs the migration of 
leukocytes from the peripheral immune system into CSF. The immune response 
may thereby limit the CNS infection. However, the immune response may be a 
two-edge sword. Neuron dysfunction and damage may develop as a consequence 
of the pro-inflammatory response (99).  
Quincke performed the first LP in 1891 to relieve increased intracranial pressure 
in children with tuberculous meningitis (100). Today, LP is essential for the 
diagnosis of CNS infections. The most common use of LP is to diagnose or 
exclude meningitis in patients presenting with the combination of fever, altered 
mental status or meningism, the sign of irritation of the meninges. Meningism 
usually are defined as the triad of neck stiffness, headache and photophobia. The 
term meningitis therefore consists of the finding of meningism and CSF 
pleocytosis, the state of elevated number of CSF WBC. In BM, all these signs 
are usually found. However, in AM and NB these findings are not observed 
consistently.  
As mentioned in the pervious chapter, there is an ongoing discussion on whether 
a LP should be performed in children with a clinical picture suspicious for NB 
(94, 101). However, if LP is performed and CSF pleocytosis is discovered, 
differentiating LM from other forms of AM in children is a common dilemma in 
LB endemic regions (102, 103). There are no studies from Norway reporting the 
epidemiology of childhood infectious meningitis or studies comparing the 
clinical and laboratorial characteristics of different groups of childhood 
meningitis. Furthermore, to our knowledge, no European studies have compared 
the clinical and laboratorial characteristics of LM and AM in children in a 
population based context. Finally, studies comparing these characteristics in BM 
and LM in children are missing. 
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1.2.4 Diagnosis of neuroborreliosis.  
Identification of the causative microbe is usually essential for the diagnosis and 
the decision of management in an infectious disease. This could be of special 
importance in all stages of LB due to the heterogeneity of clinical symptoms. In 
Europe, LB is caused by different genospesies of Bbsl, that give different clinical 
presentations of LB in general and probably in NB (49). However, culturing Bbsl 
is time-consuming and labour-intensive, and performed only in a few specialist 
microbiological laboratories. Furthermore, PCR has low sensitivity for 
demonstrating Bbsl DNA in CSF of patients with NB (104, 105). Therefore, the 
detection of antibodies against Bbsl is presently the keystone in the diagnosis of 
LB (104). 
The adaptive immune system produces specific antibodies against microbe 
antigens. Identification of antibodies against infectious agents is an indirect 
method for the diagnosis of infectious diseases. In general, IgM antibodies 
against a microbe are usually produced during early phases of an infection. Later 
during the infection, IgG antibodies are detected and the production of IgG may 
last for years after the infection has disappeared (56). However, the antibody 
production may be delayed during early phases of a clinical disease, and the 
sensitivity of an IgM or IgG test may therefore be poor at this stage. In the case 
of a present infection, a retest some weeks later may discover a rise in antibody 
titre indicating active disease. In addition, antibiotic treatment of a bacterial 
disease may influence on the production of antibodies throughout the course of 
disease (96, 106).  
The specificity of antibody tests to detect an infection may also be lowered by 
several reasons. First, the detection of IgG antibodies may be false positive due 
to earlier exposure or infection, which may have been asymptomatic. Second, 
during viral infections polyclonal B-cell activation with a high degree of cross-
reaction of polyclonal IgM antibodies between different etiological agents is 
observed (107). Finally, “natural IgM antibodies” may be found without an 
active infection being present (108). 
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Enzyme-linked immunosorbent essay (ELISA) is the recommended serological 
tests for diagnosing LB in Europe. However, Bbsl expresses numerous 
immunogenic proteins, and Bbsl genospecies expressing different proteins are 
variable distributed in geographical areas. Furthermore, the Bbsl spirochete is 
able to change the proteins expression through time and stages of LB. This 
makes the serodiagnosis of LB challenging  
The rate of discrepancy between different serological assays is significant. 
Ideally, a validation of the chosen serological Kit should be performed in each 
laboratory (53, 96). However, the VlsE protein is found highly immunogenic in 
all LB phases and contains a protein sequence common to all Bbsl species and is 
therefore recommended when diagnosing early NB (106, 109-112).  
When early disseminated LB like NB is suspected, then both Bbsl IgM and IgG 
antibody tests are indicated (112, 113). However, IgM antibodies may be 
negative during early phases of NB, both in serum and in CSF. A study in 
patients with early NB, where Bbsl antibodies have been negative and Bbsl has 
been identified by PCR, demonstrates that false negative Bbsl serology may be a 
problem in the diagnosis of NB during early phases (114). Furthermore, 
antibiotic treatment in the early phases of LB may affect the antibody response, 
and the disappearance of antibodies soon after treatment has been observed (96, 
106).  
Over time, in an endemic area of LB, a large proportion of the population over 
time is at risk of having tick bite with the inoculation of Bbsl, and thereby the 
induction of Bbsl antibody production. The seroprevalence in blood donors for 
Bbsl in a nearby region was 15 - 20 % in the adult population (93). No study of 
Bbsl seroprevalence in children has been performed in Norway. However, in 
comparable European regions the Bbsl seropositivity in children was found to be 
less than 4% (54, 62).   
EBV and CMV are the most common causes of false positive Bbsl IgM antibody 
stimulation; however they are an unusual cause of CSF pleocytosis and 
neurological manifestations in children (115). The clinical implication of such 
antibodies may therefore be small in children. Finally, natural IgM antibodies 
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(polyspesific immunoglobulins) to flagella p41 are demonstrated in our region in 
1.5 % of the adult population (108). 
In US, when an ELISA test is positive, a Western Blot test is used as a 
confirming test to avoid false positive diagnosis (116). This is a laborious and 
expensive test. Although the addition of the 2 step test increases the specificity 
of Bbsl diagnostics, the test also lowers the sensitivity of Bbsl serological 
testing. This is especially true in Europe were the Bbsl genotypes and thereby the 
antibodies are more heterogenic than in US. This test strategy cannot therefore 
be recommended in European LB diagnostics (63), and was not used at the start 
of the present studies (19). 
 In Europe, examination of the CSF is advocated in patients suspected of having 
NB, in order to confirm CSF inflammation and to detect specific intrathecal Bbsl 
antibody production. The CSF/serum Bbsl antibody index (AI) test is evaluated 
to be superior when compared to Western Blot test in the diagnosis of NB (63, 
107). A positive Bbsl AI is a unique hallmark of NB, and may be observed 
already in the first week after onset of neurological symptoms in children with 
NB (62, 96, 117). However, studies both in adults and children suggest that the 
detection of intrathecal antibody production also may be delayed during early 
phases of NB (66, 105, 118, 119).   
The reliability of performed Bb serological tests has had great impact on clinical 
and epidemiological studies in NB. However, the positive predictive value can 
be improved by strict case definitions (pre-test probability) (71).  
The updated European clinical definition of confirmed NB in children requires 
clinical symptoms suggestive of NB with cranial neuropathy as the main 
manifestation, in addition to CSF pleocytosis and a positive Bbsl AI (63). 
According to this definition, CSF evaluation is necessary for the diagnosis of 
NB, also in children with FNP. In US, the case definition of NB is not built on 
CSF evaluation and usually lumbar puncture is not performed or not reported 
(81, 120). Instead, the diagnosis is made by the two titre serological serum 
testing, making it difficult to compare European and US studies and the 
conclusions from these.  
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No NB case definition today is 100% sensitive or specific, but by using validated 
serological tests and accepted case definitions of NB the accuracy of diagnosis 
has improved, and the quality of epidemiological and clinical research is assured.  
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2. Aims of the study 
  
The overall objective was to study epidemiological, clinical and laboratory 
characteristics of childhood NB in a LB endemic area. Furthermore, we aimed to 
study causes and characteristics of all children having FNP or meningitis in a LB 
endemic area, to evaluate differences between children with non-Lyme and 
Lyme disease. The overall aim was to improve the care of children with NB.  
 
 
The specific aims of the thesis were therefore: 
  
I To study the epidemiology and the clinical characteristics of NB in 
children in a LB endemic area. 
 
II To study the relation between different clinical symptoms and laboratory 
results in children with NB, further, to study the levels of antibodies in 
serum and CSF in children with NB, and how the results of CSF 
examination are influenced by the time from debut of symptoms to the 
time when diagnostic procedures are performed. 
  
III To study the epidemiology of FNP in children in an area endemic for LB, 
how often FNP is caused by NB and the occurrence of meningitis in 
children with FNP. 
 
IV To study the epidemiology of acute infectious meningitis in childhood in 
an area endemic for LB. Furthermore, to study demographic, clinical and 
laboratorial characteristics of BM, non-Lyme AM and LM, to see how 
these characteristics may discriminate between children with different 
types of meningitis. 
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3 Materials and methods 
3.1 Study area  
Rogaland is the southern County of western Norway. The latitude of Rogaland 
(58o N to 59o N) is at the same latitude level as Alaska (51o N to 71o N). 
However, the Golf stream passing the western Norwegian coast provides a 
climate distinct different from other sub artic areas in the world. In addition, the 
combination of high mountains and the Golf stream makes the western part of 
Norway into one of the rainiest areas of the planet outside the tropic zone. The 
climate of the costal area of Rogaland is therefore suitable for I. ricinus, and the 
tick vector of LB is found in abundance in many areas. The coastal area of 
Rogaland is both the main distribution area of I. ricinus and the main residential 
area in Rogaland. Furthermore, the areas of outdoor activity of children and 
adults often are overlapping with the ticks natural habitat. 
 
 
     
Figure 6; Rogaland county (blue), study area of South Rogaland (green). 
 
The northern and southern region of Rogaland is divided by a fjord 
(Boknafjorden). The communities south and partly east of Boknafjorden; 
Egersund, Lund, Sokndal, Sandnes, Stavanger, Bjerkreim, Hå, Klepp, Time, 
Gjesdal, Sola, Randaberg, Strand, Hjelmeland, Finnøy, Rennesøy, Kvitsøy and 
Forsand together constitute the area of South-Rogaland, which is the study area 
(figure 6). Children from all these communities may be exposed to tick bites 
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through the period of year when the tick is active. The epidemiological 
differences between communities or sub-areas were not studied. 
 
 
3.2 Study population 
Stavanger University Hospital (SUS) is the only hospital with a paediatric 
department in the study area. The paediatric department receives all hospital 
admissions for acute childhood disease in the study area, for children up to 14 
years of age. Consequently, all children with suspected meningitis, NB and acute 
FNP will be referred to this hospital.  
Only children living in South Rogaland were included in the present studies. 
Annual community-based demographic data of the population were obtained 
from the Official Bureau of Statistics. The population of the South Rogaland 
region included approximately 62,000 children up to their 14th birthday 
throughout the whole study period. Norway has a public health system and all 
treatment of children is free of charge. 
 
3.3 Testing procedures 
During 1995 the paediatric department at SUS came to a consensus concerning 
the diagnostic procedures and treatment of children with possible NB. These 
recommendations were used through the whole study period. Throughout the 
whole period, children with possible NB have been discussed in plenum 
regarding diagnosis and treatment. 
During the autumn 1995 all general practitioners and ear-, nose-, and throat 
(ENT) -consultants in the region received a written recommendation that all 
children less than 14 years of age with acute FNP should be admitted without 
delay to the paediatric department at SUS. This has been a standard clinical 
practise during the study period.  
From January 1996 and through the whole study period, we aimed to investigate 
all children admitted with symptoms suggesting possible NB using the same 
procedure.  
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NB was suspected in children presenting with symptoms of FNP or other cranial 
neuropathy, radicular pain, meningismus (neck stiffness and neck pain), 
headache or cerebellar ataxia.  The procedure in these children included a 
medical history, clinical examination, blood tests and a lumbar puncture. The 
clinical symptoms, age, month of appearance of symptoms, number of days from 
debut of symptoms until hospitalisation, and results from blood tests and lumbar 
puncture were registered.  
In paper I/II data regarding demographical, clinical and laboratorial findings 
were retrospectively collected from the medical records of children suspected of 
NB in the study period from January 1996 to December 2006.  In paper III the 
data were retrospectively registered from medical records of all children with 
FNP in the study period from January 1996 to December 2004. Finally, in paper 
IV, all children with CSF pleocytosis from the age of 3 months up to their 14th 
birthday were included, and data were retrospectively registered from the study 
period from January 2001 to December 2009.  
During the whole study period, serum and cerebrospinal fluid (CSF) were 
analysed for IgM and IgG antibodies against Bbsl using an ELISA (Enzygnost 
Lyme borreliosis test) (Dade Behring, Marburg, Germany). The test was 
performed on a Bep III ELISA processor and an optical density (OD)_cut 
off_0.100 was regarded as positive. IgM- and IgG-positive controls were 
routinely used for test evaluation. From July 2006 Enzygnost Lyme link 
VlsE/IgG (Dade Behring, Siemens, Germany) was used. This test is comprised 
of a mix of whole cell detergents extracts and recombinant VlsE obtained from 
all three genopathological Bbsl species. 
From 1999, the IDEIA Lyme neuroborreliosis capture ELISA was used for 
detection of intrathecal IgM and IgG antibodies (Dako, Glostrup, Denmark). The 
antibody index is a semi-quantitative measure of intrathecal antibody production. 
Optical density (OD) is used as a measure of antibody concentration, and the 
index formula specific for this test is ODCSF/ODserum_(ODCSF-ODserum). 
The test was considered positive when the index for either IgM or IgG antibodies 
or both was > 0.3, indicating neuroborreliosis. CSF white blood cells (WBC) 
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(Fuchs Rosenthal chamber) and protein (turbidimetric technic (Roche, Basel, 
Switzerland)) were measured. Serum C-reactive protein (CRP) 
(immunoturbidimetric technic (Roche, Basel, Switzerland)) and blood WBC 
were measured in all children. When CSF pleocytosis were demonstrated, CSF 
was cultured by conventional methods. The decision to perform other 
microbiological tests was taken by the physician on duty, depending on the 
clinical presentation of the child. 
 
3.4 Diagnostic criteria and definitions 
In paper I – III children were diagnosed with NB if, in addition to suggestive 
neurological findings, either IgM or IgG antibodies for Bbsl were identified in 
serum and/or CSF. If serology was negative, but a thorough medical history 
revealed a probable erythema migrans during the past 8 weeks prior to 
submission, the child was considered to have probable NB. These criteria were 
consistent with the present European recommendations at the start of the study 
(19, 117). CSF pleocytosis was diagnosed when the lumbar puncture 
demonstrated CSF WBC > 5 x 106/L. However, as the aim was to evaluate the 
occurrence of CSF inflammation in children with NB, CSF pleocytosis was not a 
part of the NB case definition.   
FNP was defined as an acute palsy involving the facial muscles in both upper 
and lower parts of the face, either unilateral or bilateral. 
In paper IV NB was defined according to updated European NB case definitions 
(63). Only children with CSF pleocytosis were included in this study. Therefore, 
in this study NB is identical with Lyme meningitis (LM). Confirmed LM was 
defined in children with CSF pleocytosis and neurological symptoms suggestive 
of NB without any other obvious cause, in combination with intrathecal Bbsl 
antibody production (positive AI). Probable LM was defined in children with 
CSF pleocytosis and suggestive symptoms of NB cases with specific Bbsl 
antibodies or with recent or concomitant EM. Furthermore, in paper IV, CSF 
pleocytosis was defined as CSF-WBC counts > 7 X 106/L in accordance with 
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updated guidelines for children from 3 months to 16 years of age, published in 
2006 by Clinical and Laboratory Standards Institute. 
In children with CSF pleocytosis confirmed BM was defined if bacterial culture 
in CSF or blood were positive combined with sudden onset of fever, neck 
stiffness, altered consciousness or other meningeal signs. 
Children with CSF pleocytosis were defined having NLAM when BM, LM and 
non-infectious meningitis were excluded. 
 
3.5 Statistical methods  
Incidences were compared by logistic regression. Differences between groups 
were first analysed by the Kruskal-Wallis H-test when appropriate, and if 
significant, differences between groups were further analysed by the Mann-
Whitney U-test. Results were presented as median and quartiles if not otherwise 
stated. Variance was tested for by Levene’s test for equality of variances, and 
Spearman’s test was used for correlation between variables. To study the 
differences in cell counts and protein counts between the groups, Poisson 
regression analyses were performed. In these analyses, in addition to the group 
variables, days from debut of symptoms were included as a covariate to adjust 
for the effect of this factor. Differences in categorical data between groups were 
analysed by chi-square tests. All tests were 2-tailed. Data were analysed using 
the latest versions of SPSS Statistical Package. 
 
 
3.6 Ethical issues  
The data used in study I-III this were registered anonymously. Therefore, there 
was no obligation to given notification or to obtain a separate ethical licence for 
the study, since no personal data were used. The studies were approved by the 
department management. For study IV, a link key to personal data was 
established, and the study was approved by the Privacy protection supervisor of 
the Hospital established in 2011. 
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4.    Summary of results 
 
Paper I 
A total of 143 children were diagnosed with NB. All cases were diagnosed from 
April to December, with the majority from June to November. The average 
annual incidence of children with NB was 21/100.000 for the whole study group. 
The incidence varied significantly by age, with the highest incidence of 
52/100.000 in the age group 6-7 years. The most common clinical presentations 
in children with NB were symptoms of mild meningism (75%) and/or facial 
nerve palsy (69%). Based on the clinical symptoms children could be divided 
into three major groups; A: those with isolated cranial neuropathy without other 
symptoms (n=36; 25%), B: those with both cranial neuropathy and other 
neurological symptoms (n=67; 47%) and C: those with neurological symptoms 
without cranial neuropathy (n=40; 28%). Children with FNP were younger than 
children without FNP. Radicular pain, for all children in the head and neck 
region, was present in only 7% of children with NB and in 2% other cranial 
nerve involvement were reported. Significant general symptoms such as fatigue 
and anorexia were present in 6 % of children with NB, none of these had cranial 
nerve involvement. EM preceded the neurological symptoms in 27% of the 
children with NB. 
  
 
Paper II  
In this study 146 children with NB were included. They were divided into 3 
clinical groups: A (n = 37): only cranial neuropathy; B (n = 68): both cranial 
neuropathy and other neurological symptoms; C (n = 41): neurological 
symptoms without cranial neuropathy as described in paper I.  
In group A, 3 children did not have CSF pleocytosis and in 2 children a lumbar 
puncture was not performed. The rest of children in group A and all children in 
groups B and C had LM which constituted 98% of all children with NB. 
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Levels of white blood cells (WBC) and protein in CSF correlated significantly to 
numbers of days with symptoms in all children with NB. Levels of WBC and 
protein in CSF as well as the proportion of children with antibodies in serum and 
CSF were generally lowest in group A, intermediate in group B and highest in 
group C. The proportion of children with antibodies in serum and CSF and a 
positive antibody index was also related to duration of symptoms; the antibody 
index was present in 51% of children with symptoms < 7 days, and in 80% of 
children with symptoms > 7 days. Furthermore, the number of days from debut 
of symptoms to a LP was different in the three groups. However, the differences 
in levels of cells and protein in CSF between the groups were also significant 
after correcting for number of days with duration of symptoms, with higher 
levels of cells and protein in group B compared to group A, and higher in group 
C compared to group B 
 
Paper III 
A total of 115 children with acute FNP were included in the study. The annual 
incidence of children less than 14 years with FNP was 21 per 100.000 children. 
The incidence was 43/100.000 per year for children aged 6 years, and 
11/100.000 for each year in children aged 12 and 13 years.  Among all children 
with FNP, 65% were diagnosed as LB, all of these occurring from May to 
November. CSF pleocytosis was demonstrated in 78% of children with FNP and 
was present in all but one of the children with FNP diagnosed as LB. In children 
with FNP and CSF pleocytosis, the level was higher in children with LB than in 
children without LB. Nine children had CSF pleocytosis but negative Bb 
antibody titres in both serum and CSF and no history of EM. However, LB could 
not be excluded in these children, as no other infections were diagnosed.  
The median age of children with LB did not differ significantly from those 
without LB but the age distribution differed significantly between the 2 groups. 
Whereas most children with LB were 4 - 7 years of age, those without LB were 
spread more evenly throughout all ages. 
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The monthly occurrence through the year differed significantly between those 
with LB and those without. During the months from December to April none of 
the children with FNP had LB, whereas during the months from June to October, 
77% of the children had LB. No children with FNP had CSF pleocytosis during 
the months from December to April.  
 
Paper IV 
Infectious meningitis was diagnosed in 211 children (annual incidence  
38/100.000).  LM was identified in 142 children (67%), NLAM in 46 children 
(22%) and BM in 23 children (11%). Forty-six children were diagnosed with 
NLAM, and in 23 of these, a microbiological agent was identified. 
Consequently, an aetiological agent was found in 89% of children with 
infectious meningitis.  
The age distribution was different in children with LM compared to children 
with BM and NLAM. The median age of children with LM was higher than for 
children with BM. Thirty-nine per cent of children with BM but only one child 
with LM (aged 23 months) were younger than 2 years of age. Furthermore, the 
month of admission differed between groups. BM and NLAM were diagnosed 
throughout the year. LM was only diagnosed from April to December. The 
duration of symptoms in days before admission was significantly longer in LM 
compared to BM and NLAM. FNP was reported in 104 (73%) children with LM. 
No children with BM or defined NLAM had cranial nerve involvement, but three 
children with NLAM without an identified aetiological agent had FNP.  
Symptoms of cerebral involvement or signs of a systemic inflammation were 
rare in children with LM compared to children with NLAM. 
Headache and/or neck stiffness (meningism) as the only symptom was present in 
20% of children with LM. However, no children with BM or confirmed NLAM 
had meningism as the only presenting symptom. The PPV for having LM if the 
child had FNP or meningism as the only symptom was 97% for both variables. 
The NPV for not having LM if the child did not have a history of EM, or cranial 
nerve involvement or meningism as the only symptom was 95%.  
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Levels of CSF WBC and CSF protein were higher in LM compared to NLAM, 
but lower in LM compared to BM. A predominantly mononuclear CSF WBC 
was found in 99% of children with LM, more frequent than in BM and NLAM. 
The level of CSF glucose was lower in LM compared to NLAM, but higher in 
LM compared to BM. However, for all these variables, levels were overlapping 
between children with LM, BM and NLAM.  
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5.  General discussion 
The four papers included in this thesis are among the largest clinical studies of 
childhood NB, FNP and infectious meningitis from a European LB endemic 
area. The study area and the study population are of a moderate size, but the 
study period is as long as13 years. Epidemiological changes have been reported 
by us during the study period; however these results were not included in this 
thesis (121). Moreover, the population based design of the studies increases the 
importance of the results. Altogether, we consider that the studies give valuable 
contributions to epidemiological and clinical aspects of NB in children, and the 
overlapping conditions FNP and infectious meningitis. 
These studies were performed when the awareness of tick transmitted infections 
and LB was relatively high both in the population and among health workers. 
Consequently, children in the general population with LB may have been 
diagnosed early during the course of disease, usually in the local stage of LB and 
treated with appropriate antibiotics immediately. This may have had impact on 
the frequency of development of disseminated stages of LB. Therefore, we 
consider the epidemiology and the clinical characteristics observed in children 
with NB in this thesis to be largely affected by the early management of children 
exposed to bites of Bbsl infected ticks in our region.   
 
5.1    Methodological considerations 
The design of the present studies is principally retrospective. Patients were 
identified from hospital records, and data were collected retrospectively from 
medical files and registered in a database. The quality of data may therefore have 
some limitations compared to a fully prospective study. This will especially be 
the case for clinical data, such as duration of symptoms. However, 
epidemiological data as well as demographical and laboratory results are mainly 
independent of the retrospective design.   
Moreover, prior to the study period, the department came to a consensus 
regarding the diagnostic procedures and treatment both for children with possible 
NB and for children with FNP. In addition, all medical doctors in the area were 
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informed prior to the study period that all children with FNP should be sent to 
the department without delay. Consequently, during the whole study period, all 
children in South Rogaland with symptoms suspicious of NB or with FNP were 
hospitalised in one paediatric department at SUS for investigation using a 
standard protocol including a LP.  
The recommended serological tests including Bbsl AI were, with few exceptions, 
taken from children with symptoms susceptible for NB, FNP, and other cranial 
and peripheral neuropathies, as well as in children with AM. During the study 
period there has also been focus on the current practice and the diagnostic 
procedures for these patients among the paediatric staff. Even though data were 
not registered prospectively, the quality of data may therefore be close to what 
could have been achieved if they had been registered prospectively.  
In children with symptoms suspicious of infectious meningitis, a LP will 
normally be taken in any department. However, the recognition in our 
department before the study started that FNP, other cranial neuropathies as well 
as mild signs of meningism may be caused by NB led to the rigorous 
investigation of CSF in all children with these symptoms. This included children 
in good general health, but with long lasting headache as the only symptom. No 
other studies worldwide have described an identical approach to identify all 
cases of childhood NB in a defined area. The focus on this approach may also 
have brought more children with FNP and infectious meningitis without NB to 
our department, and the number of children diagnosed with these conditions may 
be more correct than in other studies without this approach.   
However, except for those with FNP, our studies included children with cranial 
neuropathy or other symptoms severe enough to warrant hospitalization. For 
those being hospitalized we had a high awareness of possible NB and of 
performing a LP throughout the study period, but it is possible that children with 
NB with minor symptoms and without cranial neuropathy were not hospitalized, 
and therefore not diagnosed. Furthermore, in children with FNP, the suspicion of 
NB was obvious and other cranial or peripheral nerve involvement was probably 
not systematically searched for, resulting in some underestimation of 
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simultaneously peripheral nerve involvement. Even partial bilateral FNP may 
have been overseen due to our study design.  
South-Rogaland has a unique advantage for population based studies of 
paediatric disease. All children in the county with acute childhood disease will 
be referred to this department. The population of the area is stable. There are no 
costs for parents when a child is admitted to hospital for acute disease. Except 
for children with mild symptoms not seeking medical help, all children within 
the study groups should have been included in the studies. Compared to many 
other studies, epidemiological data should therefore have a high reliability.  
  
   
5.2 The diagnosis of NB 
Several of the conclusions in our studies will depend on the accuracy of different 
diagnoses, especially for the diagnosis of NB. To diagnose NB may be 
challenging, due to the dependence on imprecise and indirect serological Bbsl 
tests. Furthermore, the relevance of LP and CSF analysis are debated, and 
finally, NB is reported to present with a variety of neurological signs and 
symptoms. Therefore, we suspect that the clinical characteristics incorporated in 
to case definitions are difficult to determine, when attempting to increase the 
serological pre-test probability.  
In order to evaluate the incidence of CSF pleocytosis in childhood NB, this 
parameter was not included in the case definition in paper I-III (19, 117). The 
case definition of NB used in paper I-III was based on suggested clinical 
characteristics, and Bbsl serological tests in serum and CSF. From 1999 and 
through the whole study period, Bbsl AI was included. However, in paper IV, 
current guidelines recommended in European case definitions from 2010 were 
employed (63, 122). 
  
5.2.1    Clinical characteristics 
The basic clinical characteristics in children with NB specifically mentioned in 
the European updated case definition are meningitis and FNP (63). In accordance 
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with these guidelines, we found in paper I that ¾ of children with NB had signs 
of mild meningism, the most frequent clinical finding in children with NB. 
Cranial nerve involvement was observed in 2/3 of children with NB, and FNP 
was the major manifestation. All children diagnosed with NB in our studies 
presented with at least one of these two symptoms.  
 In paper IV, we evaluated the clinical differences between NB/LM and NLAM, 
and how clinical variables could aid in the early diagnosis of NB. We found that 
in children with CSF pleocytosis, the presence of cranial nerve involvement or 
meningism with headache/neckstiffness as the only symptom, both were 
symptoms with near 100% PPV for having NB. 
Furthermore, as presented in paper IV, we found that in children with CSF 
pleocytosis without EM, cranial nerve palsy or meningism as the only symptom, 
the NPV of not having NB was 95%. Others have published different predictive 
diagnostic models for having NB in children with CSF pleocytosis, but they are 
so far not evaluated in prospective studies in regions with different Bbsl 
genospecies (123).  
 
5.2.2   CSF Inflammation 
In paper I and II, when using a definition of NB without incorporating CSF 
pleocytosis, we found that all but 2 % of children with NB had CSF pleocytosis. 
In this overwhelming majority of children with NB, nearly all had predominantly 
lymphocytic CSF pleocytosis, as also reported in paper IV. Lymphocytic CSF 
pleocytosis represent an important property of NB in children, and this is in 
accordance with recent European NB cases definitions where CSF pleocytosis is 
incorporated as an essential evidence of NB. The minority of children with NB 
without CSF pleocytosis were diagnosed as NB with acute FNP lasting less than 
48 hours, and with positive Bbsl serology in serum. In the literature, especially 
from the United States, a major group of children with NB are reported to have 
FNP without CSF pleocytosis (124). This difference may depend on the different 
distribution of Bbsl genospecies between Europe and US. Moreover, in our study 
it seems that the small group of children with FNP and negative CSF consists of 
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children diagnosed early with only peripheral involvement of both the immune 
system and the nerve system. Another possibility is that this group consists of 
children with FNP with false positive serology of LB, and therefore do not have 
NB. However, in Paper II we presented results showing how the levels of CSF 
WBC and CSF proteins increase with the duration of symptoms of NB before LP 
are performed. Therefore, these few children with FNP without CSF pleocytosis 
may be diagnosed at the very start of the intrathecal immunological activation 
initiated by the Bbsl invasion.  
 Finally, all children in our study were diagnosed within the first 6 months of NB 
manifestations, defined as early NB (105). However, in NB studies in adults, a 
significant proportion of NB patients have late NB, and a higher proportion of 
patients with late NB seem to have a normal CSF WBC count (122). 
 
5.2.3 Serological tests 
The laboratory investigations in these studies did not include attempts to detect 
Bbsl by cultivation or by Bbsl PCR tests in serum or CSF (19). Furthermore, we 
did not performed Western blot tests, that are recommended by Centers for 
Disease Control and Prevention (CDC) as the confirming serological second titre 
tests in LB diagnostics (116).  
Different Bbsl ELISA tests based on different Bbsl antigens with different 
validation qualities are commercially available (96, 107, 125). The predictive 
value of each serological test is depended on the proportion of different Bbsl 
genotypes in the study area (104). The Enzygnost Lyme borreliosis test 
performed in our study is considered to have a good predictive value in all 
human pathogenic Bbsl genospesies in Europe and is recommended in European 
NB guidelines (63, 105, 107, 111, 122).  
The Bbsl seropositivity in the healthy population may affect the interpretation of 
a positive Bbsl antibody test. The seropositivity of children in Scandinavia is 
low, but cannot be ignored (54). However, maximising the pre-test probability of 
NB by incorporating clinical and laboratory findings when interpreting the Bbsl 
antibody titre, may increase the PPV of a positive Bbsl serological test (26, 71). 
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Therefore, recent published European guidelines recommend that only patients 
with symptoms and signs suggestive of NB should be tested for positive Bbsl 
serology. In addition, analysis of CSF should be performed (63, 94, 105). 
Generally, both the IgM and the IgG antibody levels change during the course of 
an infection. In the early phase of an infection, a significant proportion of 
patients have negative serological tests, both for IgM and IgG antibodies. This is 
reported to be true also for Bbsl antibody tests performed during early NB (105). 
The consequence of this may be that some children with early NB have negative 
Bbsl antibody tests and are not diagnosed as NB. In our studies, this may have 
been the case for some children with FNP presented in paper III, and in some 
children with NLAM presented in paper IV. Therefore, the estimated proportion 
of NB in children with FNP and NLAM presented in paper III and IV may be 
to low. Consequently, the annual incidence of children with NB and LM 
presented in paper I and IV may have been underestimated. 
In paper II we studied how the frequency of positive Bbsl antibodies in children 
was dependent on the time from the start of symptoms to diagnosis. In 27% of 
the children diagnosed as NB with CSF pleocytosis, neither IgM nor IgG Bbsl 
antibodies were present in CSF. Nevertheless, as many as 76% of the children 
with NB were diagnosed within the first week of NB symptoms. Furthermore, 
children without detectable IgM and IgG Bbsl antibodies in serum were 
diagnosed after a short duration of symptoms compared to the rest of children 
with NB. These results suggest that negative antibody titres after just a few days 
after debut of symptoms must be interpreted with caution when NB is suspected.  
Furthermore, as presented in paper II, 64 % of all children with NB had a 
positive Bbsl AI when diagnosed. Only 51% of the children diagnosed with NB 
had a positive Bbsl AI if tested during the first week of symptoms, compared to 
82% when symptoms had lasted for more than 1 week. This is in accordance 
with the results of Ljøstad et al. in adult patients with NB in the neighbour region 
to the study area. They found a diagnostic sensitivity of 79% in the Bbsl AI test 
when diagnosed, 74% when symptom duration was <6 weeks, and 100% with 
symptom duration >6 weeks (126). This time limit is incorporated in the recent 
 49 
published case definition presented by one of the authors (105). After 6 weeks of 
NB symptoms, all children in our study also had positive Bbsl AI (result not 
presented in the paper). However, only a few children with NB are diagnosed 
after 6 weeks duration of symptoms. Thus, the Bbsl AI has far less than 100% 
sensitivity in diagnosing early NB in children, and the duration of symptoms 
must be taken into account also when interpreting the antibody index in children 
with suspected NB.  
Moreover, as reported previously by others, in 8 children (5%) with NB 
presented in paper II, both IgM and IgG Bb antibodies were negative in serum, 
whereas antibodies and a positive Bbsl AI were demonstrated in CSF (127). 
Therefore, NB cannot be excluded in a child with symptoms suggestive of NB 
and negative Bb antibodies in serum.  
One of the most comprehensive studies of children with NB was published by 
Christen and his co authors in 1993 (62). This epidemiological and clinical study 
of children with NB, AM and FNP is an important reference for our studies. The 
LB study by this German group is among the pioneer research in the field. Their 
study was performed within 10 years after the discovery of Bbsl, and therefore 
prior to the recognition of the three human pathogenic Bbsl genospecies present 
in Europe (14). The serological tests used in the study, were among the first 
generation of Bbsl serological tests with lower accuracy than the tests used in 
our study. Furthermore, as commented by the authors, their NB case definition 
was conservative, that could lead to underestimating of the incidence numbers. 
These aspects limit the possibilities to compare our studies to the work by 
Christen el al. However, they investigated many questions related to childhood 
NB not studied by us, and some of their results are needed to be confirmed. 
 
 
5.3   Epidemiological results 
5.3.1   Neuroborreliosis: 
As reported in paper I, the incidence of NB in South Rogaland in children up to 
14 years of age was estimated to 21/100.000. This is probably one of the highest 
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observed incidences of NB in children worldwide (119, 128). However, few 
published investigations have evaluated the incidence of NB in children in a 
strict population-based study design as in this thesis. A comprehensive 
prospective study from Germany discussed earlier estimated the incidence of NB 
in children aged 1 to 13 years to be 5.8 /100.000 (62). In a Norwegian national 
survey the incidence of disseminated LB was 8/100.000 in children aged 5 - 9 
years (72). However, the highest incidence of LB in Europe is probably found in 
Central Europe (36).   
Comparing incidences from different studies must be done with caution. The true 
incidence of NB varies greatly between areas in Europe. In addition, as 
commented by the authors, the German study used a conservative and narrow 
NB case definition, diagnosing children with NB only if Bb IgM antibodies 
where present in CSF. This has probably contributed to a lower estimate of the 
incidence than if they had uses the same criteria for NB diagnosis as in our 
studies (62). Furthermore, new generation of Bbsl serological tests used in our 
study have superior sensitivity and specificity qualities compared to those used 
in the German study from 1993.  The high incidence found in our study may of 
course be the result of a truly high occurrence of LB in our region. However, in 
addition to the strict population based design, it is also important to emphasize 
the thorough inclusion criteria for children with suspected NB in our studies as 
described above, consequently, we think we are close to the true incidence of NB 
in our area.  
It is known from several studies that the incidence of NB in children is higher 
than in adults (12, 21, 72). The most southern part of Norway may have an even 
higher incidence of LB than in our area, however, the total incidence of NB there 
in adults was reported to be 10/100.000 (72, 129).  
The incidence of NB in children as reported in paper I-II were not evenly 
distributed throughout childhood, different from the age distribution of both non-
Lyme FNP and NLAM presented in paper III and IV.  In children with NB, a 
substantially peak in incidence was found in the age group 6-7 years, in 
accordance with other studies (21, 62, 72). This age dependent incidence in 
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childhood NB has implications for the total incidence reported in other studies. 
Incidence also depends on the age groups included in a study. In the German 
article, children younger than one year and older than 13 years were not 
included. NB are extremely rare in children younger than one year and low in 
children above over 13 years of age, so the exclusion of these age groups 
compared to our study group (0-14 years of age) may have overestimated the 
general incidence of childhood NB (62).  
The age distribution of the incidence of all LB stages in all ages is bimodal, with 
a peak in childhood, and an even higher incidence in adults over 50 years (12, 
130) The peak incidence in children with NB, higher than in any other age group 
is therefore interesting and may partly be caused by specific properties for the 
development of NB in children (62). As mentioned in the introduction, one study 
has shown that children more frequently have tick bites than adults (40). 
Furthermore, the most common site for tick bites in children is the head and neck 
region, which is uncommon in adults (12). The authors postulated that this could 
contribute to the high frequency of NB in children. Furthermore, the facial nerve 
may be the cranial nerve most vulnerable to Bbsl affection due to its narrow 
intracranial pathway (92). However, FNP is an easily observed manifestation of 
NB, which is almost impossible to ignore compared to other manifestations. This 
makes it likely that the identified proportion of all children with early NB may 
be higher compared to the same proportion of adults diagnosed with NB having 
different NB manifestations.  
Why do ticks bite children so often in the head and neck region?  As described in 
the introduction, ticks are vulnerable to dehydration and do not climb high in the 
vegetation to seek their victim, (32). When playing, children expose their upper 
part of body and the head and neck area to questing ticks hanging on grass and 
bushes more frequently than adults. The mean length of the leg of a child 
exceeds 60 cm when children pass the age of 6-7 years. This is also the top level 
of mean questing height of the tick (32). A tick attaching to the leg of a child will 
less probable climb to the head and neck region, than if it attaches to the upper 
abdomen or thorax. Ticks always climb upwards and successfully hide around 
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the ear or on the scalp covered with hair of the child. In addition, the awareness 
of tick bites is low in children, leaving the tick undisturbed for a longer time and 
therefore increases the risk of being infected. We support the theory that the 
height and the activity habits in children may be important causes for both the 
peak incidence of NB in 6-7 years old children, and for the high proportion of 
children with NB presenting with FNP (62).  
 
Similar to other studies we observed a seasonal distribution of children 
diagnosed with NB (12, 36, 62, 130). All cases were diagnosed from April to 
December, and with almost 90 % of cases from June through October. With 
about a month’s delay due to the incubation period of early NB, the seasonal 
distribution of NB in children is shaped by the seasonal activity of the tick and 
the seasonal activity of children i.e. playing outside in light clothing. The 
knowledge of this specific annual incidence variation makes the physician better 
prepared during summer time to be aware of different manifestations of NB in 
children. Furthermore, parents and caretakers of children should be focused on 
finding and removing biting ticks after outdoor activities.  
 
5.3.2 Facial nerve palsy: 
In paper III we estimated the incidence of acute FNP in our region to be at least 
21/100.000 children. Although few population-based studies on FNP from areas 
endemic of LM have been published, the incidence reported in our study is high 
compared to other studies (62, 91, 92, 131). However, the childhood incidence of 
non-Lyme FNP in our study was comparable to non-endemic areas in Norway 
(91). Therefore, the high incidence of FNP seems to be due to a higher number 
of children with FNP caused by LB. Recent published papers referring our 
results have not found any other study demonstrating that LB accounts for as 
much as 65% of acute facial palsy in childhood (81, 88, 132).  Moreover, during 
the summer months, as many as 77% of the children with FNP in our region 
were diagnosed with LB. As discussed in the previous chapter, the incidence of 
children with FNP caused by LB may even be underestimated because of false 
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negative Bbsl antibody titre during early NB (96). CSF pleocytosis was 
demonstrated in 78% of children with FNP, and no other aetiology was 
identified in children with FNP and CSF pleocytosis. Supporting this theory that 
all children with FNP and CSF pleocytosis had NB, we found in our study that 
all children with FNP and CSF pleocytosis simultaneously were diagnosed from 
May to November independent of Bbsl serological findings. This is consistent 
with the occurrence of early dissemination of Bbsl within a few weeks after the 
primary infection with Bbsl, which is also found in other studies (56, 62, 88, 
133). In contrast, we observed that children diagnosed with FNP without LB was 
more evenly distributed through the years compared to children with NB. This is 
consistent with earlier observations of an even distribution of Bell’s palsy 
through the year (88). Furthermore, no cases of FNP occurring during winter 
months were associated with CSF pleocytosis, again suggesting that FNP in 
these cases may be caused by other infectious agents not associated with 
meningitis, witch are more common during winter months (131).  
FNP caused by LB was most common in the age group from 4 to 7 years, with 
an incidence as high as 43/100.000 in 6 year old children. This is consistent with 
the high rate of NB in children we found in paper I, but significantly different 
from the age distribution of children with FNP without NB (91).  
In a survey of adults from the neighbouring region to the study area, an annual 
incidence for FNP of 29/100.000 was demonstrated, which is in accordance with 
other epidemiological studies of general populations (92, 93). However, LB was 
identified as the cause of FNP in only 10% of adult patients. This further 
demonstrates that LB is a much more common cause of FNP in children 
compared to adults, even in high endemic areas, and underlines the differences in 
the aetiology of FNP between adults and children (134). 
 In the study reporting the incidence of FNP in Northern Norway, a non endemic 
area for LB, the total incidence for all age groups were 19/100.000 and lowest in 
children (<10 years : 4/100.000) (91). Comparing these results with ours, 
suggests an increasing incidence of FNP from north to south in Norway, parallel 
to the distribution of ticks and the occurrence of NB (72). This is also in 
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accordance with results from a Swedish multicentre study (133). In the total 
population of that study, the frequency of FNP caused by LB varied between 1 
and 16% and was highest along the southeast coast of Sweden. No cases were 
reported from the northern part of the country. LB was observed more common 
among children with FNP than among adults. 
 
5.3.3   Infectious meningitis: 
Paper IV is to our knowledge, the only European study reporting the specific 
incidence of LM in a population based manner. According to updated European 
NB case definitions, CSF pleocytosis is mandatory for the diagnosis of NB (63). 
Therefore, NB and LM described in paper IV may be considered as almost 
identical conditions, which are also supported by the results in paper I. It is 
therefore not surprising that we found a high incidence of LM of 26/100.000 in 
children aged from 3 months to 14 years. This is corresponding to the incidence 
of childhood NB (0-14 years) found in paper I. Furthermore, the study presented 
in paper IV is also the first to demonstrate that LM is the major cause of 
infectious meningitis in children. 67 % of all children with infectious meningitis 
and 75% of all children with AM had LM,. This may be the result of a high 
incidence of LM in our area. However, we also demonstrated a low incidence of 
both BM and NLAM (135, 136). As many as 89% of all infectious meningitis 
cases were diagnosed according to aetiology, which is a high proportion 
compared to a recent study (137). Compared to studies reporting the incidence of 
AM in LB endemic areas, we found a low incidence of meningitis caused by 
enterovirus (62, 102, 138). This may be because we did not observe any 
epidemic clusters of cases during the study period, in contrast to the majority of 
studies demonstrating a higher incidence of enterovirus infections (139). 
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5.4   Clinical and laboratorial results 
In paper I, mild meningism was found in ¾ of children and was the most 
frequent presentation of NB. In contrast to other studies, nearly all children with 
NB had CSF pleocytosis (62). Surprisingly, ¼ of children with CSF pleocytosis 
did not have clinical signs of meningitis, but only signs of acute FNP. Children 
with NB and FNP but without meningism were diagnosed earlier than children 
with meningism only. This may suggest that cranial nerve involvement is an 
earlier neurological affection than meningeal inflammation in NB. Furthermore, 
in paper III and IV, the concurrent observation of FNP and CSF pleocytosis 
was only observed in children diagnosed with NB. Finally, as children with NB 
may present with FNP as the only symptoms, this supports the argument that in 
LB endemic areas, NB should be suspected and evaluation of CSF should be 
performed in all children presenting with acute FNP (140, 141). However, during 
the winter from December to April, no children with acute FNP had CSF 
pleocytosis and LB was not identified as the aetiological cause in any of these 
children. Furthermore, no other findings with impact on management on these 
children were made by LP in these children.   
Cranial nerve involvement, mainly FNP, was found in more than two-thirds of 
the children with NB. In adults, studies have demonstrated that Bannwarth 
syndrome is the most common presentation of NB in Europe (16, 20, 129). This 
is a painful meningoradiculitis with or without paresis, and it has been suggested 
that Bannwarth syndrome is a hallmark of infection with B Garinii (16). In our 
study, nearly all children presented with CSF pleocytosis, but painful symptoms 
were reported in only a few children all in head and neck area. No studies have 
reported a difference in the Bbsl genospecies affecting children and adults, and 
such a difference is unlikely. However, a difference in the manifestations of NB 
between children and adults is clearly observed (20, 21). This difference is partly 
explained due to the difference observed in the localisation of tick bites (12). As 
described in the introduction, in addition to the common haematogenous 
pathway used by other microbes invading the CNS Bbsl may enter the CNS by 
following peripheral nerves (50). Bbsl entering the skin in the head and neck 
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region may more frequently migrate along the facial nerve, causing ipsilateral 
peripheral nevritis as shown in animal studies and reported in clinical studies 
(62, 142). The facial nerve consists mainly of motor fibres, so FNP is therefore 
the main clinical symptom when peripheral neuropathy develops. Radiculitis 
developing after tick bites in lower part of the body mainly on adults may 
however involve thoracic and lumbar nerve roots affecting both sensorial and 
motor fibres. Consequently, pain may be the major manifestation (143). 
Furthermore, the cranial nerve involvement is probably part of a more 
widespread multifocal patchy inflammation, mononeuritis multiplex (144). In 
paper I, we observed a few children with FNP and peripheral pain syndrome, 
possibly a manifestation of mononeuritis multiplex.  
 
In paper II we observed that the degree of CSF inflammation measured by 
WBC and protein in CSF differed significantly between groups with different 
clinical presentations. These differences were present even when corrected for 
the number of days from debut of symptoms to diagnosis, suggesting a 
pathophysiological link between the clinical presentation and the level of CSF 
inflammation. Children without cranial nerve involvement had higher levels of 
CSF pleocytosis and CSF protein than children with FNP. It has been speculated 
that the process of dissemination in NB may differ between meningoradiculitis 
and more diffuse LM (50). Both Bannwarth syndrome and FNP may be the 
result of a local invasion of the spirochete in the nerve root, whereas more 
diffuse meningitis may be the result of haematogenous spread (16, 50). The 
different mechanism may give both different symptoms and different laboratory 
results as demonstrated by us. Additionally, different Bbsl genospecies seem to 
present with different clinical manifestations of NB. In Europe, the most 
frequently Bbsl genospecie causing NB is reported to be B.garinii, usually 
associated with distinct clinical manifestations, CSF pleocytosis, peripheral 
neuropathy and further with positive Bbsl antibody titres and typically diagnosed 
as early NB in adults (49). However, B. afzelii is the second most frequent cause 
of NB in Europe, gives a less distinct clinical presentation which may be more 
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difficult to diagnose (49). We do not know the proportion of different Bbsl 
genospecies in our study. However, the results from others discussed above 
suggest that different genospecies may be unevenly distributed in the different 
clinical groups of NB in our studies. 
 
In clinical practice, LM and NLAM may be the two main groups of childhood 
meningitis which are difficult to distinguish during early phases. In paper IV we 
found significant differences when comparing clinical and laboratory data of 
children with LM and NLAM. Cranial neuropathy was a common and highly 
specific finding in children with LM, 95% of the children with cranial 
neuropathy having FNP. Few other microbiological agents are reported to cause 
both CSF pleocytosis and cranial neuropathy in children. In a comprehensive 
study from US, a subgroup of children with FNP underwent LP. In these 
children, 59% had CSF pleocytosis and 98 % of these had proven LB. In patients 
without CSF pleocytosis, no aetiological agent was identified (81). In paper IV, 
all but three children with CSF pleocytosis and FNP were diagnosed with LM, 
and as previously discussed, it is highly possible that these children had early 
LM as well (145). Furthermore, headache and/or neck stiffness as a single 
symptom was a specific finding in children with LM, as recently described by 
others (128). 
In summary, children with NLAM frequently had signs of involvement of both 
the meninges and the cerebral parenchyma in addition to a systemic 
inflammation. In children with LM however, signs of meningeal and peripheral 
neural inflammation dominated. This is an important and specific property of NB 
emphasized in a recent comprehensive overview (144).  
Five previous studies have compared characteristics in children with LM and 
NLAM in order to develop predictive models for the early diagnosis of children 
in the two groups (102, 103, 115, 138, 146). In accordance with our results, they 
all report a high frequency of cranial neuropathy in children with LM and no 
aetiological agent was identified in the few children with cranial neuropathy in 
those diagnosed with NLAM. However, in these studies, different definitions of 
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LM were used, and the proportion of children with an identified agent in the 
NLAM group differed significantly from our results, mainly because of a higher 
proportion of children found to be infected with enterovirus. Furthermore, age of 
inclusion, the procedure for inclusion and the routines for the evaluation of 
children susceptible for NB differ between the studies, and this may affect the 
demographical, clinical and laboratorial results. Finally, our demonstration in 
paper II of how both the duration of symptoms and the clinical characteristics in 
children with NB may affect the level of CSF inflammation and the production 
of Bbsl antibodies, makes it more complicated to compare and generalize from 
such studies. 
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6. Conclusion: 
The results of this thesis are based on a thorough work up including a lumbar 
puncture, in all children with symptoms suspicious of neuroborreliosis in an area 
endemic for Lyme borreliosis. The impact of the results is increased by the 
population based design of the study.  
One major result is the high incidence of LB of 21/100.000 children, among the 
highest incidences ever presented. The highest incidence was shown for the age 
group of four to seven years, and most patients presented between June and 
October. Two thirds of children presenting with FNP had NB, which is the 
highest proportion presented worldwide.  
The typical clinical presentation of NB in children was FNP with or without 
symptoms of mild meningism. However 1/5 of children with NB had only mild 
meningism with headache or neck stiffness without peripheral or cranial nerve 
involvement.  
The number of children with NB having antibodies in serum of CSF, and the 
level of inflammation measured in CSF depended on the clinical presentation 
and duration of symptoms. These aspects must therefore be included in the 
evaluation of children with possible NB. 
Another important result was that nearly all children with NB had lymphocytic 
CSF pleocytosis. Furthermore, pleocytosis was also present in nearly all children 
with FNP diagnoses as NB. Other causes of FNP with CSF pleocytosis were 
rare. The results underline that in areas endemic for LB, a lumbar puncture 
should be performed in all children with possible NB, including those with FNP 
as the only symptom.  
Finally, this is the first study to report that Bbsl is the most common infectious 
agent causing meningitis in children in a defined area. Simple clinical variables 
enabled us to distinguish LM and NLAM during early phases of childhood 
meningitis. 
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7.   Future perspectives 
For the near future one of the major challenges related to NB in children will still 
be diagnostic accuracy. Today, both the sensitivity and specificity of available 
tests are limited, with the possibility of both under – and over-diagnosis, 
especially during early phases of disease. While the studies presented in this 
thesis were underway, newer diagnostic possibilities have emerged. Among 
these is the discovery of the important pathophysiological role of the cytokine 
CXCL13, a chemoattractant (50). The NB immune response seems to be 
orchestrated by innate immune cells in CNS producing CXCL13 acting as a 
selectively chemotactic protein for B-lymphocytes. Furthermore it seems to have 
specific properties in the immune response in spirochete meningitis and may 
achieve an important diagnostic role in NB in the near future. This may 
particularly be the case for children with early manifestation of NB, when CSF 
pleocytosis and Bbsl antibody production has not yet started. In children with 
NB, CXCL13 seems to be specifically elevated in CSF compared to serum, so a 
lumbar puncture seems to be an inevitable procedure even in future when 
evaluating children with possible NB.  
It is a challenge that children with NB may have specific clinical and laboratorial 
constellations related to the proportion of different Bbsl genotypes present in the 
region. In our region, we have observed that children with NB may present with 
distinct clinical differences. We do not know the cause of this, but it may be 
related to differences in patient immunity, different Bbsl genospecies causing the 
disease, or even patient-spirochete interaction. In the future, NB diagnostics may 
hopefully include novel methods which are able to discriminate between 
different Bbsl genotypes. This may provide a potentially important base for 
genotype specific management of patients with NB. 
To possibly answer these questions, our research group at Stavanger University 
Hospital has designed and initiated a prospective study, aiming to study aspects 
related to the diagnostic properties of CXCL13 and the relation of different Bbsl 
genospecies to clinical symptoms in children with NB. In addition, the study area 
with its stable population has the necessary qualities for epidemiological studies 
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into LB. New knowledge about childhood NB with regard to interventional 
studies and the consequences of climate change may well be possible from 
Stavanger University Hospital and the surrounding county. 
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9.    Errata 
Paper IV
Abstact; Setting: should read A paediatric department serving all children  
(62 000) in a coastal  LB endemic region of southwestern Norway.
